{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:51Z","timestamp":1791919611337,"version":"4.3.4"},"reference-count":198,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Traditional and Complementary Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtcme.2023.10.004","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T05:38:19Z","timestamp":1704433099000},"page":"121-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Curcumin in treatment of hematological cancers: Promises and challenges"],"prefix":"10.1016","volume":"14","author":[{"given":"Maliheh","family":"Entezari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita","family":"Tayari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid Deldar Abad","family":"Paskeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin Khorsand","family":"Kheirabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Naeemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Taheriazam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shokooh","family":"Salimimoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-9579","authenticated-orcid":false,"given":"Saeed","family":"Samarghandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib1","first-page":"956","volume":"68","author":"Atrash","year":"2020","journal-title":"CAR-T treatment for hematological malignancies"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ajh.24246","article-title":"Acute myeloid leukemia--major progress over four decades and glimpses into the future","volume":"91","author":"Kantarjian","year":"2016","journal-title":"Am J Hematol"},{"issue":"10147","key":"10.1016\/j.jtcme.2023.10.004_bib3","first-page":"593","volume":"392","author":"Short","year":"2018","journal-title":"Acute myeloid leukaemia"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib4","first-page":"820","volume":"1","author":"Kadia","year":"2015","journal-title":"Toward individualized therapy in acute myeloid leukemia: Contemp Rev"},{"issue":"12","key":"10.1016\/j.jtcme.2023.10.004_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jtcme.2023.10.004_bib6","first-page":"1186","volume":"127","author":"Kantarjian","year":"2021","journal-title":"Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach"},{"key":"10.1016\/j.jtcme.2023.10.004_bib7","series-title":"Immunotherapy in Acute Myeloid Leukemia: Where We Stand","first-page":"1558","author":"Isidori","year":"2021"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib8","first-page":"394","volume":"68","author":"Bray","year":"2018","journal-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib9","first-page":"829","volume":"17","author":"Zhang","year":"2021","journal-title":"Stem Cell as Vehicles of Antibody in Treatment of Lymphoma: A Novel and Potential Targeted Therapy"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib10","first-page":"116","article-title":"Hodgkin lymphoma: A review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B\u2010cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am J Hematol"},{"issue":"20","key":"10.1016\/j.jtcme.2023.10.004_bib12","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.3390\/cancers13205154","article-title":"Relapsed\/refractory multiple myeloma in 2020\/2021 and beyond","volume":"13","author":"Podar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jtcme.2023.10.004_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/ITT.S306103","article-title":"Immunotherapy of multiple myeloma: Promise and challenges","volume":"10","author":"Abramson","year":"2021","journal-title":"ImmunoTargets Ther"},{"issue":"9983","key":"10.1016\/j.jtcme.2023.10.004_bib14","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple myeloma","volume":"385","author":"R\u00f6llig","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjh.15210","article-title":"Resistance to proteasome inhibitors and other targeted therapies in myeloma","volume":"182","author":"Wallington-Beddoe","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01162-7","article-title":"Prognostic and predictive biomarker developments in multiple myeloma","volume":"14","author":"Wallington-Beddoe","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"22","key":"10.1016\/j.jtcme.2023.10.004_bib19","first-page":"5308","volume":"51","author":"Esatbeyoglu","year":"2012","journal-title":"Curcumin\u2014from molecule to biological function"},{"key":"10.1016\/j.jtcme.2023.10.004_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-800173-8.00003-9","volume":"39","author":"Lestari","year":"2014","journal-title":"Profiles Drug Subst Excipients Relat Methodol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib21","volume":"28","author":"Akbar","year":"2018","journal-title":"Critical review on curcumin as a therapeutic agent: From traditional herbal medicine to an ideal therapeutic agent"},{"key":"10.1016\/j.jtcme.2023.10.004_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2021.111438","article-title":"Curcumin as a great contributor for the treatment and mitigation of colorectal cancer","volume":"152","author":"Karthika","year":"2021","journal-title":"Exp Gerontol"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051033","article-title":"A review of curcumin and its derivatives as anticancer agents","volume":"20","author":"Tomeh","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1389450121666200925150022","article-title":"Curcumin and its multi-target function against Pain and inflammation: an update of pre-clinical Data","volume":"22","author":"Uddin","year":"2021","journal-title":"Curr Drug Targets"},{"issue":"13","key":"10.1016\/j.jtcme.2023.10.004_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26134036","article-title":"Curcumin as a natural Remedy for Atherosclerosis: a pharmacological review","volume":"26","author":"Singh","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jtcme.2023.10.004_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124440","article-title":"Curcumin in metabolic health and disease","volume":"13","author":"Jabczyk","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/10408398.2018.1552244","article-title":"Cellular and molecular mechanisms of curcumin in prevention and treatment of disease","volume":"60","author":"Patel","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/molecules21030264","article-title":"Curcumin and health","volume":"21","author":"Pulido-Moran","year":"2016","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.jtcme.2023.10.004_bib29","first-page":"6768","volume":"35","author":"Kumar","year":"2021","journal-title":"Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib30","first-page":"189","volume":"36","author":"Abadi","year":"2022","journal-title":"Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib31","first-page":"1006","volume":"21","author":"Ashrafizadeh","year":"2020","journal-title":"Curcumin therapeutic modulation of the wnt signaling pathway"},{"key":"10.1016\/j.jtcme.2023.10.004_bib32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.semcancer.2020.10.010","article-title":"Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics","volume":"73","author":"Patra","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"10.1016\/j.jtcme.2023.10.004_bib33","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/biomedicines9091086","article-title":"The role of curcumin in cancer treatment","volume":"9","author":"Zoi","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.jtcme.2023.10.004_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091183","article-title":"Curcumin reduces colorectal cancer cell proliferation and migration and Slows in vivo growth of liver Metastases in Rats","volume":"9","author":"Herrero de la Parte","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90754-x","article-title":"The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells","volume":"11","author":"Semlali","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib36","first-page":"291","article-title":"Co-Treatment with ginsenoside 20(S)-Rg3 and curcumin increases Radiosensitivity of MDA-MB-231 cancer cell line","volume":"46","author":"Changizi","year":"2021","journal-title":"Iran J Med Sci"},{"issue":"10","key":"10.1016\/j.jtcme.2023.10.004_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10101591","article-title":"Curcumin and carnosic acid cooperate to inhibit proliferation and alter mitochondrial function of metastatic prostate cancer cells","volume":"10","author":"Ossikbayeva","year":"2021","journal-title":"Antioxidants"},{"issue":"8","key":"10.1016\/j.jtcme.2023.10.004_bib38","first-page":"1745","volume":"34","author":"Ashrafizadeh","year":"2020","journal-title":"Potential therapeutic effects of curcumin mediated by JAK\/STAT signaling pathway: Review"},{"key":"10.1016\/j.jtcme.2023.10.004_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121255","article-title":"Curcumin-tannic acid-poloxamer nanoassemblies enhance curcumin's uptake and bioactivity against cancer cells in vitro","volume":"610","author":"Sunoqrot","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtcme.2023.10.004_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111773","article-title":"Ruthenium(II)-curcumin liposome nanoparticles: synthesis, characterization, and their effects against cervical cancer","volume":"204","author":"Lakshmi","year":"2021","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.jtcme.2023.10.004_bib41","series-title":"Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer","author":"Azarian","year":"2022"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib42","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.7962","article-title":"Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT","volume":"45","author":"Zhou","year":"2021","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12964-020-00652-4","article-title":"Curcumin derivative C212 inhibits Hsp90 and eliminates both growing and quiescent leukemia cells in deep dormancy","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun Signal"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib44","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12204","article-title":"Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine-resistant myeloid leukemia cells","volume":"24","author":"Tseng","year":"2021","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/ptr.6316","article-title":"Curcumin and tetrahydrocurcumin induce cell death in Ara-C-resistant acute myeloid leukemia","volume":"33","author":"Tseng","year":"2019","journal-title":"Phytother Res"},{"issue":"10","key":"10.1016\/j.jtcme.2023.10.004_bib46","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.18632\/aging.202893","article-title":"microRNA-1246-containing extracellular vesicles from acute myeloid leukemia cells promote the survival of leukemia stem cells via the LRIG1-meditated STAT3 pathway","volume":"13","author":"Chen","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jtcme.2023.10.004_bib47","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.2147\/CMAR.S274590","article-title":"LINC00265\/miR-4500 Axis accelerates acute lymphoblastic leukemia progression by enhancing STAT3 signals","volume":"13","author":"Zhao","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.2021013201","article-title":"The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation","volume":"139","author":"Amaya","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtcme.2023.10.004_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S228610","article-title":"Curcumin combined with thalidomide reduces expression of STAT3 and bcl-xL, leading to apoptosis in acute myeloid leukemia cell lines","volume":"14","author":"Mohammadi Kian","year":"2020","journal-title":"Drug Des Dev Ther"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/aps.2017.160","article-title":"C1206, a novel curcumin derivative, potently inhibits Hsp90 and human chronic myeloid leukemia cells in vitro","volume":"39","author":"Fan","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"22","key":"10.1016\/j.jtcme.2023.10.004_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26226923","article-title":"Structural design, synthesis and antioxidant, antileishmania, anti-inflammatory and anticancer activities of a novel quercetin acetylated derivative","volume":"26","author":"da Silva","year":"2021","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.jtcme.2023.10.004_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195781","article-title":"Polyphenolic flavonoid compound quercetin effects in the treatment of acute myeloid leukemia and myelodysplastic syndromes","volume":"26","author":"Torello","year":"2021","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/01635581.2020.1767167","article-title":"Synergistic induction of apoptosis by quercetin and curcumin in chronic myeloid leukemia (K562) cells: II. Signal transduction pathways involved","volume":"73","author":"Mutlu Altunda\u011f","year":"2021","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/01635581.2018.1380208","article-title":"Synergistic induction of apoptosis by quercetin and curcumin in chronic myeloid leukemia (K562) cells","volume":"70","author":"Mutlu Altunda\u011f","year":"2018","journal-title":"Nutr Cancer"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010204","article-title":"Phenolic compounds cannabidiol, curcumin and quercetin cause mitochondrial dysfunction and suppress acute lymphoblastic leukemia cells","volume":"22","author":"Olivas-Aguirre","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/toxres\/tfab001","article-title":"Black pepper and piperine induce anticancer effects on leukemia cell line","volume":"10","author":"Banerjee","year":"2021","journal-title":"Toxicol Res"},{"key":"10.1016\/j.jtcme.2023.10.004_bib57","article-title":"Anticancer applications and pharmacological properties of piperidine and piperine: a comprehensive review on molecular mechanisms and therapeutic perspectives","volume":"12","author":"Mitra","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ajco.13449","article-title":"Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance","volume":"17","author":"Usman","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.jtcme.2023.10.004_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106029","article-title":"Acute myeloid leukemia: therapy resistance and a potential role for tetraspanin membrane scaffolds","volume":"137","author":"Floren","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib60","first-page":"401","article-title":"Antiproliferative potential of piperine and curcumin in drug-resistant human leukemia cancer cells are mediated via autophagy and apoptosis induction, S-phase cell cycle arrest and inhibition of cell invasion and migration","volume":"25","author":"Li","year":"2020","journal-title":"J buon"},{"issue":"10","key":"10.1016\/j.jtcme.2023.10.004_bib61","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/s41374-021-00640-3","article-title":"Curcumin attenuates Adriamycin-resistance of acute myeloid leukemia by inhibiting the lncRNA HOTAIR\/miR-20a-5p\/WT1 axis","volume":"101","author":"Liu","year":"2021","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtcme.2023.10.004_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.coi.2020.11.006","article-title":"Inflammasome activation and evasion by bacterial pathogens","volume":"68","author":"Ta","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib63","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jtcme.2023.10.004_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109595","article-title":"Pyroptosis: a new frontier in cancer","volume":"121","author":"Fang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"10.1016\/j.jtcme.2023.10.004_bib65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41419-019-1883-8","article-title":"The role of pyroptosis in cancer: pro-cancer or pro-\"host\"?","volume":"10","author":"Xia","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtcme.2023.10.004_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109052","article-title":"Mechanism and regulation of pyroptosis-mediated in cancer cell death","volume":"323","author":"Ruan","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jtcme.2023.10.004_bib67","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fonc.2019.00971","article-title":"Induction of pyroptosis and its implications in cancer management","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15384047.2022.2058862","article-title":"Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines","volume":"23","author":"Zhou","year":"2022","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jtcme.2023.10.004_bib69","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.31661\/gmj.v7i0.921","article-title":"Curcumin and curcumin-loaded nanogel induce apoptosis activity in K562 chronic myelogenous leukemia cells","volume":"7","author":"Khatamsaz","year":"2018","journal-title":"Galen Med J"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/nano11112974","article-title":"CD123-Targeted nano-curcumin molecule enhances cytotoxic efficacy in leukemic stem cells","volume":"11","author":"Nirachonkul","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jtcme.2023.10.004_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118491","article-title":"Hyaluronic acid-based nanoplatforms for Doxorubicin: a review of stimuli-responsive carriers, co-delivery and resistance suppression","volume":"272","author":"Ashrafizadeh","year":"2021","journal-title":"Carbohydr Polym"},{"issue":"20","key":"10.1016\/j.jtcme.2023.10.004_bib72","doi-asserted-by":"crossref","first-page":"16857","DOI":"10.1021\/acsami.7b02863","article-title":"Novel curcumin liposome modified with hyaluronan targeting CD44 plays an anti-leukemic role in acute myeloid leukemia in vitro and in vivo","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib73","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/03639045.2018.1562462","article-title":"FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells","volume":"45","author":"Tima","year":"2019","journal-title":"Drug Dev Ind Pharm"},{"issue":"13","key":"10.1016\/j.jtcme.2023.10.004_bib74","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1021\/acs.langmuir.7b04335","article-title":"Microfluidic assisted nanoprecipitation of PLGA nanoparticles for curcumin delivery to leukemia jurkat cells","volume":"34","author":"Leung","year":"2018","journal-title":"Langmuir"},{"key":"10.1016\/j.jtcme.2023.10.004_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpb.2016.12.032","article-title":"Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells","volume":"114","author":"Tima","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"10.1016\/j.jtcme.2023.10.004_bib76","first-page":"1303","article-title":"Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells","volume":"54","author":"Zhu","year":"2016","journal-title":"Pharm Biol"},{"key":"10.1016\/j.jtcme.2023.10.004_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/968981","article-title":"Curcumin and its analogue induce apoptosis in leukemia cells and have additive effects with bortezomib in cellular and xenograft models","volume":"2015","author":"Nagy","year":"2015","journal-title":"BioMed Res Int"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055934","article-title":"Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"issue":"26","key":"10.1016\/j.jtcme.2023.10.004_bib79","doi-asserted-by":"crossref","first-page":"21918","DOI":"10.18632\/oncotarget.4204","article-title":"Curcumin inhibits in vitro and in vivo chronic myelogenous leukemia cells growth: a possible role for exosomal disposal of miR-21","volume":"6","author":"Taverna","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtcme.2023.10.004_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2015.05.003","article-title":"Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT\/mTOR pathway and BCR\/ABL gene expression in Ph+ acute lymphoblastic leukemia","volume":"65","author":"Guo","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib81","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3892\/or.2016.4944","article-title":"Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells","volume":"36","author":"Zeng","year":"2016","journal-title":"Oncol Rep"},{"issue":"12","key":"10.1016\/j.jtcme.2023.10.004_bib82","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00109-014-1198-2","article-title":"Inactivation of FoxM1 transcription factor contributes to curcumin-induced inhibition of survival, angiogenesis, and chemosensitivity in acute myeloid leukemia cells","volume":"92","author":"Zhang","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/tox.20716","article-title":"Induction of apoptosis by curcumin in murine myelomonocytic leukemia WEHI-3 cells is mediated via endoplasmic reticulum stress and mitochondria-dependent pathways","volume":"28","author":"Huang","year":"2013","journal-title":"Environ Toxicol"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib84","first-page":"6777","article-title":"Curcumin differentially affects cell cycle and cell death in acute and chronic myeloid leukemia cells","volume":"15","author":"Mart\u00ednez-Castillo","year":"2018","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib85","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s43440-020-00073-7","article-title":"Curcumin augments therapeutic efficacy of TRAIL-based immunotoxins in leukemia","volume":"72","author":"Surapally","year":"2020","journal-title":"Pharmacol Rep"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib86","first-page":"3055","article-title":"Anti-vascular endothelial growth factor targeting by curcumin and thalidomide in acute myeloid leukemia cells","volume":"18","author":"Salemi","year":"2017","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"19","key":"10.1016\/j.jtcme.2023.10.004_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195785","article-title":"Co-treatments of edible curcumin from turmeric rhizomes and chemotherapeutic drugs on cytotoxicity and FLT3 protein expression in leukemic stem cells","volume":"26","author":"Chueahongthong","year":"2021","journal-title":"Molecules"},{"issue":"Supplement","key":"10.1016\/j.jtcme.2023.10.004_bib88","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.4103\/0973-1482.172111","article-title":"The autophagy induced by curcumin via MEK\/ERK pathway plays an early anti-leukemia role in human Philadelphia chromosome-positive acute lymphoblastic leukemia SUP-B15 cells","volume":"14","author":"Guo","year":"2018","journal-title":"J Cancer Res Therapeut"},{"key":"10.1016\/j.jtcme.2023.10.004_bib89","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3389\/fonc.2019.00484","article-title":"Curcumin induces apoptotic cell death via inhibition of PI3-kinase\/AKT pathway in B-precursor acute lymphoblastic leukemia","volume":"9","author":"Kuttikrishnan","year":"2019","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s11658-021-00275-8","article-title":"LncRNA UCA1 promotes development of gastric cancer via the miR-145\/MYO6 axis","volume":"26","author":"Yang","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.jtcme.2023.10.004_bib91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ijbiomac.2021.09.089","article-title":"Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence","volume":"191","author":"Paskeh","year":"2021","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib92","first-page":"15019","article-title":"miR-21 expression predicts prognosis in diffuse large B-cell lymphoma","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000346441","article-title":"Inhibition of miR-21 induces biological and behavioral alterations in diffuse large B-cell lymphoma","volume":"130","author":"Gu","year":"2013","journal-title":"Acta Haematol"},{"issue":"29","key":"10.1016\/j.jtcme.2023.10.004_bib94","doi-asserted-by":"crossref","first-page":"45730","DOI":"10.18632\/oncotarget.10160","article-title":"STAT5 induces miR-21 expression in cutaneous T cell lymphoma","volume":"7","author":"Lindahl","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3349\/ymj.2020.61.1.20","article-title":"Curcumin inhibits the proliferation, migration, invasion, and apoptosis of diffuse large B-cell lymphoma cell line by regulating MiR-21\/VHL Axis","volume":"61","author":"Chen","year":"2020","journal-title":"Yonsei Med J"},{"issue":"7","key":"10.1016\/j.jtcme.2023.10.004_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520943792","article-title":"MiR-28-5p mediates the anti-proliferative and pro-apoptotic effects of curcumin on human diffuse large B-cell lymphoma cells","volume":"48","author":"Kang","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jtcme.2023.10.004_bib97","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4605329","article-title":"hsa-MicroRNA-28-5p inhibits diffuse large B-cell lymphoma cell proliferation by downregulating 14-3-3\u03b6 expression","volume":"2022","author":"Yan","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jtcme.2023.10.004_bib98","series-title":"CDK12 Activates MYC to Repress miR-28-5p\/EZH2 and Amplifies Tonic BCR Signaling to Promote the Development of Diffuse Large B-Cell Lymphoma","author":"Liu","year":"2022"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188574","article-title":"Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma","volume":"1876","author":"Mohan","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jtcme.2023.10.004_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.03.025","article-title":"Regulation of Nuclear Factor-KappaB (NF-\u03baB) signaling pathway by non-coding RNAs in cancer: inhibiting or promoting carcinogenesis?","volume":"509","author":"Mirzaei","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtcme.2023.10.004_bib101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.abb.2018.04.012","article-title":"Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice","volume":"648","author":"Guorgui","year":"2018","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib102","first-page":"587","article-title":"Correlation between lncRNA H19 rs2839698 polymorphism and susceptibility to NK\/T cell lymphoma in Chinese population","volume":"26","author":"Zhang","year":"2021","journal-title":"J buon"},{"key":"10.1016\/j.jtcme.2023.10.004_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","article-title":"Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR","volume":"631","author":"Liu","year":"2017","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.jtcme.2023.10.004_bib104","first-page":"402","article-title":"Curcumin inhibits proliferation and enhances apoptosis in A549 cells by downregulating lncRNA UCA1","volume":"73","author":"Wang","year":"2018","journal-title":"Pharmazie"},{"issue":"10","key":"10.1016\/j.jtcme.2023.10.004_bib105","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41419-019-1886-5","article-title":"LncRNA SNHG14\/miR-5590-3p\/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1\/PD-L1 checkpoint","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib106","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1016\/j.ygeno.2020.06.051","article-title":"The role of circular RNAs in hematological malignancies","volume":"112","author":"Lin","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.jtcme.2023.10.004_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110167","article-title":"Artesunate induces apoptosis, autophagy and ferroptosis in diffuse large B cell lymphoma cells by impairing STAT3 signaling","volume":"88","author":"Chen","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.jtcme.2023.10.004_bib108","article-title":"The acetyltransferase KAT5 inhibitor NU 9056 promotes apoptosis and inhibits JAK2\/STAT3 pathway in extranodal NK\/T cell lymphoma","author":"Xu","year":"2021","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.jtcme.2023.10.004_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103639","article-title":"Interleukin-6 reverses Adriamycin resistance in nasal NK\/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2\/STAT3\/NF-\u03baB\/P65 pathway","volume":"85","author":"Gao","year":"2021","journal-title":"Environ Toxicol Pharmacol"},{"issue":"10","key":"10.1016\/j.jtcme.2023.10.004_bib110","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.2020009404","article-title":"Dimethyl fumarate induces ferroptosis and impairs NF-\u03baB\/STAT3 signaling in DLBCL","volume":"138","author":"Schmitt","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib111","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.21873\/anticanres.15709","article-title":"Dimethyl fumarate induces apoptosis via inhibiting NF-\u03baB and STAT3 signaling in adult T-cell leukemia\/lymphoma cells","volume":"42","author":"Maeta","year":"2022","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.jtcme.2023.10.004_bib112","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/jid.2010.86","article-title":"Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling","volume":"130","author":"Zhang","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ijc.23477","article-title":"Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells","volume":"123","author":"Mackenzie","year":"2008","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib114","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/BSR20110043","article-title":"Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-\u03baB signalling in lymphoma-bearing mice","volume":"32","author":"Das","year":"2012","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jtcme.2023.10.004_bib115","doi-asserted-by":"crossref","DOI":"10.2174\/1871520623666230727104849","article-title":"Pulsatilla saponin A Inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma through the JAK2\/STAT3 signaling pathway","author":"Liu","year":"2023","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib116","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/tcr-22-2045","article-title":"REG\u03b3 promotes mantle cell lymphoma cell apoptosis by downregulating NF-\u03baB signaling","volume":"12","author":"Zeng","year":"2023","journal-title":"Transl Cancer Res"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib117","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.3892\/mmr.2016.4899","article-title":"Omacetaxine mepesuccinate induces apoptosis and cell cycle arrest, promotes cell differentiation, and reduces telomerase activity in diffuse large B-cell lymphoma cells","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jtcme.2023.10.004_bib118","article-title":"Curcumin in combination with omacetaxine suppress lymphoma cell growth, migration, invasion, and angiogenesis via inhibition of VEGF\/Akt signaling pathway","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.jtcme.2023.10.004_bib119","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1080\/10428194.2021.1894642","article-title":"miR-145-5p exerts anti-tumor effects in diffuse large B-cell lymphoma by regulating S1PR1\/STAT3\/AKT pathway","volume":"62","author":"Gao","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib120","first-page":"1102","article-title":"PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma","volume":"12","author":"Huang","year":"2022","journal-title":"Am J Cancer Res"},{"issue":"14","key":"10.1016\/j.jtcme.2023.10.004_bib121","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.18632\/aging.203319","article-title":"Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-\u03b2\/Smad3 signaling pathway","volume":"13","author":"Zhang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jtcme.2023.10.004_bib122","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/978-981-15-4272-5_44","article-title":"Autophagy and lymphoma","volume":"1207","author":"Zheng","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jtcme.2023.10.004_bib123","article-title":"Identification and assessment of necroptosis-related genes in clinical prognosis and immune cells in diffuse large B-cell lymphoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.jtcme.2023.10.004_bib124","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41375-022-01634-w","article-title":"APR-246 triggers ferritinophagy and ferroptosis of diffuse large B-cell lymphoma cells with distinct TP53 mutations","volume":"36","author":"Hong","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib125","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-020-64828-1","article-title":"Co-Delivery of doxorubicin and curcumin with polypeptide nanocarrier for synergistic lymphoma therapy","volume":"10","author":"Guo","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jtcme.2023.10.004_bib126","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11626-018-0288-9","article-title":"Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells","volume":"54","author":"Namkaew","year":"2018","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"16","key":"10.1016\/j.jtcme.2023.10.004_bib127","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2217\/nnm-2021-0100","article-title":"Glutathione-responsive PLGA nanocomplex for dual delivery of doxorubicin and curcumin to overcome tumor multidrug resistance","volume":"16","author":"Lai","year":"2021","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/08982104.2020.1720718","article-title":"Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells","volume":"31","author":"Varshosaz","year":"2021","journal-title":"J Liposome Res"},{"key":"10.1016\/j.jtcme.2023.10.004_bib129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv Drug Deliv Rev."},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib130","first-page":"337","volume":"42","author":"Fundar\u00f2","year":"2000","journal-title":"Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after iv administration to rats"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib131","first-page":"327","volume":"10","author":"Zara","year":"2002","journal-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib132","first-page":"289","volume":"25","author":"Jain","year":"2008","journal-title":"Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib133","first-page":"E254","volume":"8","author":"Reddy","year":"2006","journal-title":"Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib134","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3892\/ol.2020.12167","article-title":"Antineoplastic effect of a novel nanosized curcumin on cutaneous T cell lymphoma","volume":"20","author":"Trochopoulos","year":"2020","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.leukres.2013.10.011","article-title":"Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines","volume":"38","author":"Yosifov","year":"2014","journal-title":"Leuk Res"},{"issue":"47","key":"10.1016\/j.jtcme.2023.10.004_bib136","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1038\/sj.onc.1208864","article-title":"Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma","volume":"24","author":"Uddin","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.intimp.2014.02.024","article-title":"Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1 (IL-1\u03b1 and IL-1\u03b2) via modulation of AP-1 and NF-IL6 in lymphoma bearing mice","volume":"20","author":"Das","year":"2014","journal-title":"Int Immunopharm"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib138","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3109\/10428194.2014.889824","article-title":"Long-term effect of curcumin down-regulates expression of tumor necrosis factor-\u03b1 and interleukin-6 via modulation of E26 transformation-specific protein and nuclear factor-\u03baB transcription factors in livers of lymphoma bearing mice","volume":"55","author":"Das","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtcme.2023.10.004_bib139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biopha.2017.09.078","article-title":"Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination","volume":"97","author":"Zhao","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3892\/or.2012.2091","article-title":"Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2\/M phase and inhibition of mTOR phosphorylation","volume":"29","author":"Qiao","year":"2013","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib141","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2019.12.129","article-title":"Curcumin exerts anti-tumor effects on diffuse large B cell lymphoma via regulating PPAR\u03b3 expression","volume":"524","author":"Zhang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.jtcme.2023.10.004_bib142","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1158\/1535-7163.MCT-08-0541","article-title":"Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines","volume":"7","author":"Hussain","year":"2008","journal-title":"Mol Cancer Therapeut"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib143","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bcp.2005.04.043","article-title":"Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1\/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma","volume":"70","author":"Shishodia","year":"2005","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib144","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10565-020-09565-x","article-title":"Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma","volume":"37","author":"Zhao","year":"2021","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10.1016\/j.jtcme.2023.10.004_bib145","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41375-018-0331-6","article-title":"B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src\/STAT3 and c-Cbl-mediated degradation of SOCS3","volume":"33","author":"Lin","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jtcme.2023.10.004_bib146","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.phymed.2018.06.038","article-title":"Arctiin is a pharmacological inhibitor of STAT3 phosphorylation at tyrosine 705 residue and potentiates bortezomib-induced apoptotic and anti-angiogenic effects in human multiple myeloma cells","volume":"55","author":"Lee","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jtcme.2023.10.004_bib147","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/OTT.S282334","article-title":"Physalis alkekengi var. franchetii extracts exert antitumor effects on non-small cell lung cancer and multiple myeloma by inhibiting STAT3 signaling","volume":"14","author":"Fu","year":"2021","journal-title":"OncoTargets Ther"},{"issue":"7","key":"10.1016\/j.jtcme.2023.10.004_bib148","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.4049\/jimmunol.171.7.3863","article-title":"Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells","volume":"171","author":"Bharti","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jtcme.2023.10.004_bib149","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.2147\/CMAR.S237330","article-title":"S1PR2 knockdown promotes migration and invasion in multiple myeloma cells via NF-\u03baB activation","volume":"12","author":"Pang","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib150","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4149\/neo_2020_200923N1010","article-title":"Magnolol suppressed cell migration and invasion and induced cell apoptosis via inhibition of the NF-\u03baB signaling pathway by upregulating microRNA-129 in multiple myeloma","volume":"68","author":"Jin","year":"2021","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib151","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41374-018-0114-8","article-title":"Overexpression of HIF-1\u03b1 contributes to melphalan resistance in multiple myeloma cells by activation of ERK1\/2, Akt, and NF-\u03baB","volume":"99","author":"Tsubaki","year":"2019","journal-title":"Lab Invest"},{"key":"10.1016\/j.jtcme.2023.10.004_bib152","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.canlet.2021.08.009","article-title":"Albendazole inhibits NF-\u03baB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myeloma","volume":"520","author":"Yi","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtcme.2023.10.004_bib153","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tiv.2017.12.001","article-title":"Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-\u03baB pathways","volume":"47","author":"Allegra","year":"2018","journal-title":"Toxicol Vitro"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib154","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2002-05-1320","article-title":"Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis","volume":"101","author":"Bharti","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib155","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.3390\/ijms13044831","article-title":"Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-\u03baB\/JNK","volume":"13","author":"Bai","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtcme.2023.10.004_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110048","article-title":"Disulfiram\/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways","volume":"126","author":"Xu","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"26","key":"10.1016\/j.jtcme.2023.10.004_bib157","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.7150\/jca.35098","article-title":"Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways","volume":"10","author":"Shen","year":"2019","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib158","first-page":"870","article-title":"Gossypol induces apoptosis of multiple myeloma cells through the JUN-JNK pathway","volume":"10","author":"Zhang","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib159","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41419-021-03535-9","article-title":"Ciclopirox and bortezomib synergistically inhibits glioblastoma multiforme growth via simultaneously enhancing JNK\/p38 MAPK and NF-\u03baB signaling","volume":"12","author":"Su","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtcme.2023.10.004_bib160","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3083041","article-title":"Curcumin synergistically enhances the cytotoxicity of arsenic trioxide in U266 cells by increasing arsenic uptake","volume":"2021","author":"Han","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1475-2867-13-25","article-title":"Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway","volume":"13","author":"Hu","year":"2013","journal-title":"Cancer Cell Int"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib162","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.7314\/APJCP.2013.14.11.6469","article-title":"Effects of arsenic trioxide alone and in combination with bortezomib in multiple myeloma RPMI 8266 cells","volume":"14","author":"Elmahi","year":"2013","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib163","first-page":"1155","article-title":"Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells","volume":"2","author":"McCafferty-Grad","year":"2003","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.jtcme.2023.10.004_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111632","article-title":"Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways","volume":"139","author":"Ganesan","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.jtcme.2023.10.004_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/ph14121292","article-title":"Acquired drug resistance enhances imidazoquinoline efflux by P-glycoprotein","volume":"14","author":"Pulukuri","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib166","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1139\/bcb-2019-0377","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells","volume":"98","author":"Gao","year":"2020","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.jtcme.2023.10.004_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112331","article-title":"Novel curcumin derivatives as P-glycoprotein inhibitors: molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin","volume":"198","author":"Sagnou","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/ph9040071","article-title":"Curcumin as a modulator of P-glycoprotein in cancer: challenges and perspectives","volume":"9","author":"Lopes-Rodrigues","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib169","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1158\/1535-7163.MCT-08-0905","article-title":"Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model","volume":"8","author":"Sung","year":"2009","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.jtcme.2023.10.004_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117503","article-title":"IGF-1 promotes multiple myeloma progression through PI3K\/Akt-mediated epithelial-mesenchymal transition","volume":"249","author":"Peng","year":"2020","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib171","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jcb.29383","article-title":"miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K\/AKT\/mTOR pathway","volume":"121","author":"Liu","year":"2020","journal-title":"J Cell Biochem"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib172","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00277-018-3247-3","article-title":"PI3K\/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft","volume":"97","author":"Chen","year":"2018","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib173","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12885-021-07833-5","article-title":"Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K\/AKT signaling pathway","volume":"21","author":"He","year":"2021","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.jtcme.2023.10.004_bib174","first-page":"3719","article-title":"Novel curcumin analogs, GO-Y030 and GO-Y078, are multi-targeted agents with enhanced abilities for multiple myeloma","volume":"31","author":"Kudo","year":"2011","journal-title":"Anticancer Res"},{"issue":"16","key":"10.1016\/j.jtcme.2023.10.004_bib175","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1080\/15384101.2020.1792686","article-title":"A Gli inhibitor GANT61 suppresses cell proliferation, promotes cell apoptosis and induces G1\/G0 cycle retardation with a dose- and time-dependent manner through inhibiting Notch pathway in multiple myeloma","volume":"19","author":"Zhang","year":"2020","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib176","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bbrc.2015.10.076","article-title":"Notch increased vitronection adhesion protects myeloma cells from drug induced apoptosis","volume":"467","author":"Ding","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib177","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2007-07-102632","article-title":"Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy","volume":"111","author":"Nefedova","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/ol.2014.2127","article-title":"Apoptosis of mouse myeloma cells induced by curcumin via the Notch3-p53 signaling axis","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib179","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/15384047.2014.986997","article-title":"Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups","volume":"16","author":"Gomez-Bougie","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib180","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molonc.2008.09.006","article-title":"Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells","volume":"2","author":"Park","year":"2008","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib181","first-page":"102","article-title":"Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs","volume":"29","author":"Mujtaba","year":"2012","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib182","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3892\/ol.2015.2946","article-title":"A preliminary study of the effect of curcumin on the expression of p53 protein in a human multiple myeloma cell line","volume":"9","author":"Li","year":"2015","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib183","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00277-009-0831-6","article-title":"Reversal of multidrug resistance by curcumin through FA\/BRCA pathway in multiple myeloma cell line MOLP-2\/R","volume":"89","author":"Xiao","year":"2010","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.jtcme.2023.10.004_bib184","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/1381612823666170317164639","article-title":"Effect and mechanism of curcumin on EZH2 - miR-101 regulatory feedback loop in multiple myeloma","volume":"24","author":"Wu","year":"2018","journal-title":"Curr Pharmaceut Des"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib185","first-page":"70","article-title":"[Inhibitory effect of curcumin on angiogenesis induced by brain derived neurotrophic factor from multiple myeloma cells]","volume":"14","author":"Wang","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib186","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4149\/neo_2011_02_118","article-title":"Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3\/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro","volume":"58","author":"Ghoneum","year":"2011","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.jtcme.2023.10.004_bib187","first-page":"464","article-title":"[Curcumin increases the chemosensitivity of multiple myeloma to bortezomib by inhibiting the Notch1 signaling pathway]","volume":"27","author":"Ge","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.jtcme.2023.10.004_bib188","first-page":"684","article-title":"[Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism]","volume":"19","author":"Zhang","year":"2011","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib189","first-page":"1108","article-title":"Curcumin-induced promoter hypermethylation of the mammalian target of rapamycin gene in multiple myeloma cells","volume":"17","author":"Chen","year":"2019","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib190","first-page":"762","article-title":"[Effect of curcumin on expression of survivin, Bcl-2 and Bax in human multiple myeloma cell line]","volume":"15","author":"Liu","year":"2007","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.jtcme.2023.10.004_bib191","first-page":"33","article-title":"[Reversal of multidrug resistance of the drug resistant human multiple myeloma cell line MOLP-2\/R by curcumin and its relation with FA\/BRCA pathway]","volume":"30","author":"Xiao","year":"2009","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.jtcme.2023.10.004_bib192","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy","volume":"12","author":"Tang","year":"2021","journal-title":"Thorac Cancer"},{"issue":"4","key":"10.1016\/j.jtcme.2023.10.004_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28041623","article-title":"The role of ferroptosis and cuproptosis in curcumin against hepatocellular carcinoma","volume":"28","author":"Liu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jtcme.2023.10.004_bib194","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8859181","article-title":"Curcumin targets both apoptosis and necroptosis in acidity-tolerant prostate carcinoma cells","volume":"2021","author":"Lee","year":"2021","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jtcme.2023.10.004_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216307","article-title":"Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence","volume":"570","author":"Qin","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jtcme.2023.10.004_bib196","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2017.01.023","article-title":"Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes","volume":"119","author":"Campesi","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtcme.2023.10.004_bib197","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.phrs.2018.12.021","article-title":"Gender-specific therapeutic approach in arterial hypertension \u2013 challenges ahead","volume":"141","author":"Tadic","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jtcme.2023.10.004_bib198","series-title":"Gender and Colorectal Cancer","first-page":"105","author":"DeCosse","year":"1993"}],"container-title":["Journal of Traditional and Complementary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2225411023001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2225411023001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:57:18Z","timestamp":1762412238000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2225411023001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":198,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2225411023001116"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcme.2023.10.004","relation":{},"ISSN":["2225-4110"],"issn-type":[{"value":"2225-4110","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin in treatment of hematological cancers: Promises and challenges","name":"articletitle","label":"Article Title"},{"value":"Journal of Traditional and Complementary Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcme.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by The Center for Food and Biomolecules, National Taiwan University.","name":"copyright","label":"Copyright"}]}}